1. Clinical & Scientific Overview
Zinc (Zinc Sulphate Monohydrate / Zinc Acetate / Zinc Gluconate) (TIP-MED-000193, Reference Code [10.9]) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Essential Trace Element Cofactor (>300 Metalloenzymes: DNA/RNA Polymerase, Alkaline Phosphatase, Carbonic Anhydrase, Superoxide Dismutase, Epithelial & Immune Repair).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Representative Indian Market Examples (Edition 2.7 Ch 10 [10.9], p. 131): Zinfate / Zinconia (Zuventus—20 mg elemental Zn), Zincovit (Apex—Multivitamin + Zinc), Z&D (Alkem), Ascazin (50 mg elemental Zn) — Strengths & Dosage Forms: Oral Dispersible Tablets & Syrups: 20 mg Elemental Zinc (equivalent to ~55 mg Zinc Sulphate Monohydrate); Adult Therapeutic Tablets: 50 mg Elemental Zinc (equivalent to 140 mg Zinc Sulphate Monohydrate or 220 mg Zinc Sulphate Heptahydrate)
Oral Dispersible Tablets & Syrups: 20 mg Elemental Zinc (equivalent to ~55 mg Zinc Sulphate Monohydrate); Adult Therapeutic Tablets: 50 mg Elemental Zinc (equivalent to 140 mg Zinc Sulphate Monohydrate or 220 mg Zinc Sulphate Heptahydrate)
3. Mechanism of Action & Pharmacodynamics
Essential Trace Element Cofactor (>300 Metalloenzymes: DNA/RNA Polymerase, Alkaline Phosphatase, Carbonic Anhydrase, Superoxide Dismutase, Epithelial & Immune Repair) acting on target receptor/enzyme pathways in Vitamins, Minerals & Nutritional Supplements (Ch 10): clinical efficacy is mediated via Essential Trace Element Cofactor (>300 Metalloenzymes: DNA/RNA Polymerase, Alkaline Phosphatase, Carbonic Anhydrase, Superoxide Dismutase, Epithelial & Immune Repair) for WHO / ICMR Mandatory Adjunct to ORS in Acute Infectious Diarrhoea in children (20 mg OD for 14 days—reduces stool volume and prevents recurrence for 2–3 months!) and adults; promotion of wound, pressure ulcer, diabetic foot ulcer, and burn healing; acrodermatitis enteropathica; immune convalescence; dysgeusia/hypogeusia (impaired taste); Wilson's Disease (Zinc Acetate 50 mg TDS induces intestinal metallothionein to block dietary copper absorption!)..
4. Therapeutic Indications & Evidence-Supported Uses
- WHO / ICMR Mandatory Adjunct to ORS in Acute Infectious Diarrhoea in children (20 mg OD for 14 days—reduces stool volume and prevents recurrence for 2–3 months!) and adults
- promotion of wound, pressure ulcer, diabetic foot ulcer, and burn healing
- acrodermatitis enteropathica
- immune convalescence
- dysgeusia/hypogeusia (impaired taste)
- Wilson's Disease (Zinc Acetate 50 mg TDS induces intestinal metallothionein to block dietary copper absorption!)
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: General Adult Reference: Nutritional / Immune / Wound Supplementation: 20 mg to 50 mg Elemental Zinc once daily after food for 2–4 weeks. Acute Diarrhoea: 20 mg elemental zinc once daily for 10–14 days. (Wilson's Disease maintenance: 50 mg elemental zinc three times daily on an empty stomach). Follow physician prescription.
Administration & Meal Timing: Take WITH or immediately AFTER a meal (except in Wilson's disease)—taking zinc on an empty stomach causes intense gastric irritation, metallic nausea, and vomiting! | Once daily after lunch or dinner.
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal: Excreted primarily via faeces (~90%); safe in short courses in CKD, though avoid chronic high doses. Hepatic: Zinc supplementation (20–50 mg/day) is often beneficial in hepatic cirrhosis (where urinary zinc wasting impairs urea cycle ornithine transcarbamylase ammonia detoxification).
Renal: Excreted primarily via faeces (~90%); safe in short courses in CKD, though avoid chronic high doses. Hepatic: Zinc supplementation (20–50 mg/day) is often beneficial in hepatic cirrhosis (where urinary zinc wasting impairs urea cycle ornithine transcarbamylase ammonia detoxification).
Renal: Excreted primarily via faeces (~90%); safe in short courses in CKD, though avoid chronic high doses. Hepatic: Zinc supplementation (20–50 mg/day) is often beneficial in hepatic cirrhosis (where urinary zinc wasting impairs urea cycle ornithine transcarbamylase ammonia detoxification).
7. Contraindications, Precautions & High-Risk Warnings
- Chronic Zinc Overuse Causes Severe Copper-Deficiency Anaemia & Myeloneuropathy! Taking high-dose Zinc (≥50 mg elemental Zn/day) continuously for months induces intestinal metallothionein, which traps dietary Copper inside enterocytes and excretes it in faeces—leading to hypocupraemic microcytic/sideroblastic anaemia, neutropenia, and irreversible spinal cord neuropathy!
Key Clinical Precautions: Renal: Excreted primarily via faeces (~90%); safe in short courses in CKD, though avoid chronic high doses. Hepatic: Zinc supplementation (20–50 mg/day) is often beneficial in hepatic cirrhosis (where urinary zinc wasting impairs urea cycle ornithine transcarbamylase ammonia detoxification).
8. Adverse Effects Profile
- Nausea, epigastric burning, metallic/astringent taste in mouth (especially if taken on an empty stomach or as dispersible zinc sulphate), abdominal cramping.
- Zinc-Induced Copper Deficiency (sideroblastic anaemia, severe leukopenia/neutropenia, sensory ataxia/myeloneuropathy) with chronic megadose intake; reduction in HDL cholesterol with prolonged high doses.
- Monitor for severe hypersensitivity, organ toxicity, or dose-limiting adverse events.
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Chelation Blockade (Space by ≥2–4 Hours!): Zinc chelates and blocks the absorption of Fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin), Tetracyclines (doxycycline), Penicillamine, Trientine, and Integrase Inhibitors (dolutegravir)! Furthermore, high-dose Oral Iron and Calcium compete with Zinc for intestinal absorption if taken simultaneously in large doses
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: Always take Zinc tablets after lunch or dinner to avoid stomach nausea. Space by at least 2–3 hours from Ciprofloxacin, Levofloxacin, or Doxycycline antibiotics. Post-COVID/viral illness patients should not continue 50 mg Zinc tablets indefinitely beyond 2–4 weeks, as excess zinc blocks copper and weakens blood counts.
- Meal & Clock Timing Instruction: Take WITH or immediately AFTER a meal (except in Wilson's disease)—taking zinc on an empty stomach causes intense gastric irritation, metallic nausea, and vomiting! (Once daily after lunch or dinner.)
- Missed Dose Protocol: Take after the next meal; never double.
- Geriatric Dispensing Pearl: Beneficial for 2–4 weeks in elderly patients with diabetic foot ulcers, venous leg ulcers, or acute gastroenteritis, but audit chronic prescriptions to prevent prolonged duplicate zinc intake (e.g., taking both Zincovit and Ascazin).
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Oral Dispersible Tablets & Syrups: 20 mg Elemental Zinc (equivalent to ~55 mg Zinc Sulphate Monohydrate); Adult Therapeutic Tablets: 50 mg Elemental Zinc (equivalent to 140 mg Zinc Sulphate Monohydrate or 220 mg Zinc Sulphate Heptahydrate)
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) • Ch 10 [10.9] (p. 131)
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: HANDBOOK_SOURCE_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.2] Vitamin D3 (Cholecalciferol — including 60,000 IU High-Strength Preparations) — Fat-Soluble Secosteroid Prohormone (Converted Hepatically to 25(O
- [10.3] Vitamin B-Complex (Therapeutic B1, B2, B3, B5, B6, B7, B9, B12 Combinations) — Water-Soluble Coenzyme Vitamin Complex (Carbohydrate, Amino Acid
- [10.4] Multivitamins and Multiminerals — Comprehensive Micronutrient Supplement (Fat-Soluble Vitamins A, D
- [10.5] Calcium Carbonate (Typically Combined with Vitamin D3) — Inorganic Calcium Salt (40% Elemental Calcium—Highest Elemental Y